Metraipolis › archive › dc_d850fade1d8a

Real-world outcomes of stereotactic body radiotherapy plus sintilimab and bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus — Europe PMC PMID:41495001

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41495001
DOI
10.1093/oncolo/oyaf439
License (as archived)
solo-consultazione
Archived
2026-11-07T05:45:21.280Z
SHA-256 of the archived text
eaf6e6900856182782c5324a7ccf3fd8cefb1a75412cd0074ba22d240334c30c
Stable URL of this page
https://metraipolis.com/documento/dc_d850fade1d8a

How to cite

Real-world outcomes of stereotactic body radiotherapy plus sintilimab and bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus — Europe PMC PMID:41495001 — Europe PMC (en), https://europepmc.org/article/MED/41495001 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d850fade1d8a (Metraipolis archive dc_d850fade1d8a, sha256 eaf6e6900856182782c5324a7ccf3fd8cefb1a75412cd0074ba22d240334c30c)
BibTeX
@misc{dcd850fade1d8a,
  title = {Real-world outcomes of stereotactic body radiotherapy plus sintilimab and bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus — Europe PMC PMID:41495001},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41495001},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d850fade1d8a; sha256 eaf6e6900856182782c5324a7ccf3fd8cefb1a75412cd0074ba22d240334c30c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41495001. Agents can read the archived copy with the MCP tool read_document.